Epinephrine / Lidocaine
Epinephrine and lidocaine is a local anesthetic combination used to numb tissue for surgical, dental, and anorectal procedures.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 50 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Epinephrine / Lidocaine: Patient Information Guide
A plain-language walkthrough of Epinephrine / Lidocaine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Epinephrine and lidocaine products are used across several formulations to numb tissue for procedures or to relieve anorectal discomfort. Supported uses include:
- Local or regional anesthesia for surgical, diagnostic, and therapeutic procedures in adults and children (Lidocaine Hydrochloride and Epinephrine injection, various routes)
- Anesthesia for dental and oral surgery procedures (Lidocaine Hydrochloride and Epinephrine injection; Flavalta solution; Lidocaine subcutaneous/submucosal injection; 2% Xylocaine Dental Solutions; Lignospan Forte and Lignospan Standard solutions)
- Obstetrical (childbirth-related) anesthesia (Lidocaine Hydrochloride and Epinephrine injection)
- Nerve block techniques including brachial plexus, intercostal, lumbar epidural, and caudal epidural blocks (Lidocaine Hydrochloride and Epinephrine and LIDOCAINE HCl and EPINEPHRINE injections)
- Temporary relief of anorectal itching, pain, soreness, and burning from hemorrhoids and anorectal disorders (The Solution topical spray; The Solu Tion topical inhaler/aerosol; Gold Label topical spray; Numquick Analgesic topical spray)
⚙️How it works▾
Lidocaine blocks pain by stabilizing nerve cell membranes — it prevents the tiny electrical signals that nerves use to send pain messages from starting or traveling. Epinephrine narrows the blood vessels around the injection site, which slows how quickly lidocaine is absorbed into the general bloodstream. This keeps the numbing effect working longer right where it's needed, while reducing the chance of too much lidocaine reaching the rest of the body.
💊How it's taken▾
Injection forms are always given by a trained healthcare provider — the route (infiltration, epidural, nerve block, etc.), amount, and concentration are chosen based on the procedure, patient age, weight, and health status. Topical spray and aerosol forms are applied directly to the affected skin area as directed on the product label. No injection product in this combination should be self-administered at home.
- Injection products are not recommended for intrathecal (into spinal fluid) use
- Children, elderly patients, and people who are seriously ill require reduced doses
- Single-dose vials without preservatives should be discarded after one use; do not save leftover solution
🤒Side effects — in detail▾
Like all local anesthetics, side effects are generally dose-related and most common when blood levels of lidocaine are higher than intended. Common effects include:
- Lightheadedness, dizziness, or drowsiness
- Tingling or numbness around the mouth or lips
- Nausea or vomiting
- Headache or backache (especially after epidural or spinal procedures)
- Low blood pressure
- Shivering
- Blurred or double vision
- Skin reactions such as hives or rash (allergic)
Serious reactions — including seizures, loss of consciousness, severe drop in blood pressure, cardiac arrest, or bluish skin discoloration (a sign of methemoglobinemia) — require immediate emergency care. Tell your care team right away if you feel anything unusual after receiving an injection.
⚠️Warnings & precautions▾
- Dose-related toxicity: Too much lidocaine in the bloodstream — from excessive dose, accidental blood vessel injection, or rapid absorption — can cause brain and heart toxicity. Early signs include restlessness, ringing in the ears, metallic taste, mouth tingling, tremors, or sudden drowsiness. Untreated, this can lead to seizures, cardiac arrest, or death.
- Methemoglobinemia: A rare but dangerous blood condition where the blood can't carry oxygen properly. Watch for bluish skin or abnormal blood color. Higher-risk individuals include infants under 6 months, people with G6PD deficiency, and those taking certain other medications.
- Sulfite allergy: The injection contains sodium metabisulfite, which can trigger severe allergic or asthma-like reactions in susceptible people, particularly those with asthma.
- Tissue injury risk: Using epinephrine-containing products in areas with limited blood supply — fingers, toes, nose, ear, or penis — can cause ischemia (tissue damage from lack of blood flow).
- Intra-articular use is not approved: Injecting local anesthetics into joints after surgery has been linked to chondrolysis (cartilage damage), including permanent joint damage requiring surgery.
- Liver disease: Lidocaine is metabolized by the liver; liver impairment can lead to dangerous drug accumulation. Reduced doses and closer monitoring are needed.
🔀What it interacts with▾
Several drug combinations can cause serious problems when used with lidocaine and epinephrine injection:
- MAO inhibitors and tricyclic antidepressants: Can cause severe, prolonged high blood pressure — combination should generally be avoided
- Ergot-type oxytocic drugs: Combination can cause dangerous high blood pressure or stroke — avoid together
- Nonselective beta-blockers: Can lead to severe high blood pressure and a dangerously slow heart rate — generally avoid
- Other local anesthetics: Toxic effects add together; use with caution and careful monitoring
- Nitrates, certain antibiotics (sulfonamides), antimalarials, anticonvulsants, acetaminophen, metoclopramide, and others: Increase the risk of methemoglobinemia
- Potent inhaled general anesthetics: Combination with epinephrine can trigger serious heart rhythm problems
- Phenothiazines and butyrophenones (certain antipsychotics): May blunt epinephrine's effect on blood pressure
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you have a known allergy to lidocaine, any amide-type local anesthetic, or any other ingredient in the product
- Tell your provider about all medications you take, especially antidepressants, blood pressure medications, and drugs used during anesthesia
- Tell your provider if you have liver disease — lidocaine processing may be impaired, raising the risk of toxicity
- Tell your provider if you have heart disease or poor blood vessel circulation — reduced doses and closer monitoring are needed
- People with peripheral vascular disease or blood pressure-related vascular disease may react more strongly to epinephrine
- Tell your provider if you have G6PD deficiency, lung problems, or any condition affecting blood oxygen — methemoglobinemia risk is higher
- Pregnant patients: lidocaine crosses the placenta and can affect the fetus; local anesthetics used during labor may cause temporary effects in the newborn. Discuss risks with your provider.
- Breastfeeding: lidocaine and its breakdown products appear in breast milk in small amounts; discuss timing with your provider
- Children require doses adjusted for age, weight, and health status
- Older adults and debilitated patients should receive reduced doses
🚑If you take too much▾
Too much lidocaine reaching the bloodstream can cause seizures, severe low blood pressure, slowed or stopped breathing, and cardiac arrest. Emergency management focuses on keeping the airway open, providing oxygen, and supporting breathing and circulation. If seizures occur and don't stop with breathing support, anti-seizure medications may be used by the treating team. Dialysis is not useful for removing lidocaine in an overdose situation.
📡Pharmacodynamics — effects in the body▾
At recommended doses, lidocaine blocks nerve conduction to produce numbness and pain relief in the targeted area. If blood levels rise too high, lidocaine can depress the cardiovascular system — lowering heart rate, blood pressure, and cardiac output. Epinephrine can stimulate the heart (beta-adrenergic effect) and narrow blood vessels (alpha-adrenergic effect), which in the context of central nerve blocks may influence blood pressure in complex ways. The net cardiovascular effect at appropriate doses is usually mild, modest low blood pressure.
🔬Pharmacokinetics — how your body processes it▾
After injection, lidocaine is completely absorbed; how fast depends on the injection site and whether epinephrine is present (epinephrine slows absorption). Between 60–80% of lidocaine in the blood is bound to proteins. It crosses both the blood-brain barrier and the placenta. The liver rapidly breaks lidocaine down into metabolites, and about 90% is excreted in the urine as metabolites, with less than 10% leaving the body unchanged. The typical half-life (the time for blood levels to fall by half) after an intravenous dose is about 1.5 to 2 hours, but this can more than double in people with liver disease. Kidney disease does not significantly affect how lidocaine itself is processed, though its metabolites may accumulate.
📦How to store it▾
stored at 20° to 25°C (68° to 77°F) . Protect from light.
📄 Written from Epinephrine / Lidocaine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Epinephrine / Lidocaine — the kind of thing our pharmacy team would talk through with you at the counter.
What is this drug actually used for? ▾
Will I feel any side effects from the injection? ▾
What should I tell my doctor before getting this injection? ▾
Are there any warning signs I should watch for after receiving an injection? ▾
Can I use the topical spray at home on my own? ▾
Is this safe if I have liver problems? ▾
Is Epinephrine / Lidocaine available over the counter? ▾
When was Epinephrine / Lidocaine first available? ▾
Who makes Epinephrine / Lidocaine? ▾
💬 Answers drafted from Epinephrine / Lidocaine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Epinephrine / Lidocaine comes
Epinephrine / Lidocaine is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Lidocaine Hydrochloride and Epinephrine injection is used to produce local or regional anesthesia for surgery, dental and oral surgery, diagnostic and therapeutic procedures, and obstetrical procedures in adults and children
- Flavalta solution is used specifically for local anesthesia for dental procedures by nerve block or infiltration techniques
- Lidocaine (subcutaneous/submucosal injection) is indicated for local anesthesia for dental procedures by nerve block or infiltration techniques
- LIDOCAINE HCl and EPINEPHRINE injection is used for infiltration, peripheral nerve block, and central neural techniques including lumbar and caudal epidural blocks
- Lidocaine Hydrochloride and Epinephrine injection is not recommended for intrathecal (into the spinal fluid) use
- Multi-dose vials containing antimicrobial preservatives should not be used for epidural or caudal anesthesia — single-dose vials without preservatives are used for those techniques
- Unused portions of preservative-free single-dose vials should be discarded after initial use
- These injections are given only by trained healthcare providers using proper technique; the dose and route are tailored to the procedure and the patient
Show 16 more strengths Show fewer strengths
Topical spray
How this form is used
- The Solution spray temporarily relieves local and anorectal itching, discomfort, and pain associated with anorectal disorders or inflammation
- Gold Label spray temporarily relieves itching, pain, soreness, and burning due to hemorrhoids, hemorrhoidal tissues, or piles
- Numquick Analgesic spray temporarily relieves local discomfort or pain and swelling or burning associated with anorectal disorders
- Apply topically to the affected anorectal area as directed on the product label
- Use only as directed — do not exceed the recommended amount or frequency stated on the label
Topical cream, ointment or gel
Inhaler
How this form is used
- The Solu Tion is used for the temporary relief of local and anorectal itching, discomfort, and pain associated with anorectal disorders or anorectal inflammation
- The Solu Tion is applied topically to the affected area; follow the directions on the product label
Oral solution
📊 Epinephrine / Lidocaine across the U.S. market
How Epinephrine / Lidocaine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Epinephrine / Lidocaine is used
A general measure of how commonly Epinephrine / Lidocaine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Epinephrine / Lidocaine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Epinephrine / Lidocaine prescribed? Of the 1,596 medications we measure, Epinephrine / Lidocaine ranks #468 by Medicaid prescriptions — more than 71% of them.
Utilization by Epinephrine / Lidocaine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution Most dispensed
Summed across the 8 of 48 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1010751
epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution
Summed across the 4 of 35 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1010759
30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/ML Injection
Summed across the 1 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1867943
20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection
Summed across the 2 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1010688
10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/ML Injection
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1867938
5 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection
Summed across the 1 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1867998
epinephrine 0.005 MG/ML / lidocaine hydrochloride 5 MG/ML Injectable Solution
Summed across the 2 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1010745
10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection
Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1868028
30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection
Summed across the 1 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1867996
10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1867992
Other Epinephrine / Lidocaine products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 17 of 39 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Epinephrine / Lidocaine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 39 of 165 listed Epinephrine / Lidocaine NDCs with Medicaid activity.
🔍 Compare Epinephrine / Lidocaine products
A representative set of FDA-listed product records for Epinephrine / Lidocaine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| LIDOCAINE HYDROCHLORIDE 5 g/100 mL; EPINEPHRINE HYDROCHLORIDE 0.01 g/100 mL | Topical | Scalp Tech Inc | OTC MONOGRAPH DRUG | View NDC → |
| 💊Injection | ||||
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | A-S Medication Solutions | NDA | View NDC → |
| 0.005; 20 mg/mL; mg/mL | Epidural; Infiltration; Intracaudal; Perineural | A-S Medication Solutions | NDA | Find on DailyMed ↗ |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mL; EPINEPHRINE BITARTRATE 0.005 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | B. Braun Medical Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Benco Dental | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.02 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Benco Dental | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Benco Dental | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.02 mg/mL | Submucosal | Benco Dental | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | Benco Dental | ANDA | View NDC → |
| 0.02; 20 mg/mL; mg/mL | Subcutaneous | Benco Dental | ANDA | View NDC → |
| 10; 10 mcg/mL; mg/mL | Infiltration | Cardinal Health | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 10 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | Cardinal Health 107, LLC | ANDA | View NDC → |
| 10; 10 mcg/mL; mg/mL | Infiltration | Cardinal Health 107, LLC | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Darby Dental Supply, LLC | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.02 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Darby Dental Supply, LLC × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Darby Dental Supply, LLC | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.02 mg/mL | Submucosal | Darby Dental Supply, LLC | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | Darby Dental Supply, LLC | ANDA | View NDC → |
| 0.02; 20 mg/mL; mg/mL | Subcutaneous | Darby Dental Supply, LLC | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 10 mcg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Dentsply Pharmaceutical | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mcg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Dentsply Pharmaceutical | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 10 mcg/mL | Submucosal | Dentsply Pharmaceutical | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 20 mcg/mL | Submucosal | Dentsply Pharmaceutical | ANDA | View NDC → |
| 10; 20 mcg/mL; mg/mL | Subcutaneous | Dentsply Pharmaceutical | ANDA | View NDC → |
| 20; 20 mcg/mL; mg/mL | Subcutaneous | Dentsply Pharmaceutical | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 5 mg/mL; EPINEPHRINE BITARTRATE 0.005 mg/mL | Infiltration, Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | Fresenius Kabi USA, LLC × 2 listings | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mL; EPINEPHRINE BITARTRATE 0.005 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE 0.005 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 0.01; 10 mg/mL; mg/mL | Infiltration; Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 10; 20 mcg/mL; mg/mL | Infiltration; Perineural | General Injectables & Vaccines × 2 listings | ANDA | View NDC → |
| 0.005; 20 mg/mL; mg/mL | Epidural; Infiltration; Intracaudal; Perineural | General Injectables & Vaccines, Inc × 2 listings | NDA | View NDC → |
| 0.01; 10 mg/mL; mg/mL | Infiltration; Perineural | General Injectables & Vaccines, Inc | NDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Infiltration; Perineural | General Injectables & Vaccines, Inc | NDA | View NDC → |
| 5; 5 mcg/mL; mg/mL | Infiltration; Perineural | General Injectables & Vaccines, Inc | ANDA | View NDC → |
| 10; 10 mcg/mL; mg/mL | Infiltration | General Injectables & Vaccines, Inc | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 5 mg/mL; EPINEPHRINE 5 mcg/mL | Infiltration, Perineural | Henry Schein, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 10 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration | Henry Schein, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 10 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | Henry Schein, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | Henry Schein, Inc. | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE 0.005 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Henry Schein, Inc. | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | Henry Schein, Inc. | NDA | View NDC → |
| 0.005; 20 mg/mL; mg/mL | Epidural; Infiltration; Intracaudal; Perineural | Henry Schein, Inc. × 2 listings | NDA | View NDC → |
| 0.01; 10 mg/mL; mg/mL | Infiltration; Perineural | Henry Schein, Inc. × 2 listings | NDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Infiltration; Perineural | Henry Schein, Inc. × 2 listings | NDA | View NDC → |
| 5; 5 mcg/mL; mg/mL | Infiltration; Perineural | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| 10; 10 mcg/mL; mg/mL | Infiltration | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| 10; 20 mcg/mL; mg/mL | Infiltration; Perineural | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Henry Schein Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.02 mg/mL | Submucosal | Henry Schein Inc. | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | Henry Schein Inc. × 2 listings | ANDA | View NDC → |
| 0.02; 20 mg/mL; mg/mL | Subcutaneous | Henry Schein Inc. × 2 listings | ANDA | View NDC → |
| EPINEPHRINE BITARTRATE 0.005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | HF Acquisition Co LLC, DBA HealthFirst | NDA | View NDC → |
| EPINEPHRINE 10 mcg/mL; LIDOCAINE HYDROCHLORIDE 20 mg/mL | Infiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 10 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | NDA | View NDC → |
| 0.005; 20 mg/mL; mg/mL | Epidural; Infiltration; Intracaudal; Perineural | HF Acquisition Co LLC, DBA HealthFirst | NDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Infiltration; Perineural | HF Acquisition Co LLC, DBA HealthFirst × 4 listings | NDA | View NDC → |
| 10; 10 mcg/mL; mg/mL | Infiltration; Perineural | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 10; 20 mcg/mL; mg/mL | Infiltration; Perineural | HF Acquisition Co LLC, DBA HealthFirst × 4 listings | ANDA | View NDC → |
| EPINEPHRINE 5 mcg/mL; LIDOCAINE HYDROCHLORIDE 5 mg/mL | Infiltration, Perineural | Hospira, Inc. | ANDA | View NDC → |
| EPINEPHRINE 5 mcg/mL; LIDOCAINE HYDROCHLORIDE 15 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | ANDA | View NDC → |
| EPINEPHRINE 5 mcg/mL; LIDOCAINE HYDROCHLORIDE 15 mg/mL | Epidural | Hospira, Inc. | ANDA | View NDC → |
| EPINEPHRINE 5 mcg/mL; LIDOCAINE HYDROCHLORIDE 20 mg/mL | Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | ANDA | View NDC → |
| EPINEPHRINE 10 mcg/mL; LIDOCAINE HYDROCHLORIDE 10 mg/mL | Infiltration, Perineural | Hospira, Inc. × 2 listings | ANDA | View NDC → |
| EPINEPHRINE 10 mcg/mL; LIDOCAINE HYDROCHLORIDE 20 mg/mL | Infiltration, Perineural | Hospira, Inc. × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 5 mg/mL; EPINEPHRINE 5 mcg/mL | Infiltration, Perineural | Hospira, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 10 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | Hospira, Inc. × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 15 mg/mL; EPINEPHRINE 5 mcg/mL | Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 15 mg/mL; EPINEPHRINE 5 mcg/mL | Epidural | Hospira, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE 5 mcg/mL | Epidural, Infiltration, Intracaudal, Perineural | Hospira, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | Hospira, Inc. × 2 listings | ANDA | View NDC → |
| 5; 5 mcg/mL; mg/mL | Infiltration; Perineural | Hospira, Inc. | ANDA | View NDC → |
| 5; 15 mcg/mL; mg/mL | Epidural | Hospira, Inc. | ANDA | View NDC → |
| 5; 15 mcg/mL; mg/mL | Epidural; Infiltration; Intracaudal; Perineural | Hospira, Inc. | ANDA | View NDC → |
| 5; 20 mcg/mL; mg/mL | Epidural; Infiltration; Intracaudal; Perineural | Hospira, Inc. | ANDA | View NDC → |
| 10; 10 mcg/mL; mg/mL | Infiltration; Perineural | Hospira, Inc. | ANDA | View NDC → |
| 10; 20 mcg/mL; mg/mL | Infiltration; Perineural | Hospira, Inc. | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | IQ Dental | ANDA | View NDC → |
| 10; 10 mcg/mL; mg/mL | Infiltration; Perineural | IT3 Medical LLC | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | NDC, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | NDC, Inc. | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | NDC, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Novocol Pharmaceutical of Canada, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Patterson Dental | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.02 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Patterson Dental | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Patterson Dental | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.02 mg/mL | Submucosal | Patterson Dental | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | Patterson Dental | ANDA | View NDC → |
| 0.02; 20 mg/mL; mg/mL | Subcutaneous | Patterson Dental | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | ProPharma Distribution | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | ProPharma Distribution | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | Remedyrepack Inc. × 2 listings | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Safco Dental Supply Co | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | Safco Dental Supply Co × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Septodont, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.02 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | Septodont, Inc. | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Septodont, Inc. × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | Septodont, Inc. | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.02 mg/mL | Submucosal | Septodont, Inc. × 2 listings | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | Septodont, Inc. × 2 listings | ANDA | View NDC → |
| 0.02; 20 mg/mL; mg/mL | Subcutaneous | Septodont, Inc. × 2 listings | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 10 mg/mL; EPINEPHRINE 10 mcg/mL | Infiltration, Perineural | Sportpharm LLC | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Infiltration, Perineural | Sportpharm LLC | NDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 0.01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mL | Submucosal | The Atlanta Dental Supply Company DBA Advanced Dental Products | ANDA | View NDC → |
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE BITARTRATE 0.01 mg/mL | Submucosal | The Atlanta Dental Supply Company DBA Advanced Dental Products | ANDA | View NDC → |
| 0.01; 20 mg/mL; mg/mL | Subcutaneous | The Atlanta Dental Supply Company DBA Advanced Dental Products | ANDA | View NDC → |
| 💊Oral solution | ||||
| LIDOCAINE HYDROCHLORIDE 20 mg/mL; EPINEPHRINE 10 mcg/mL | — | Hospira, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 0.1; 50 mg/mL; mg/mL | Topical | Dermal Source, Inc. | OTC MONOGRAPH NOT FINAL | View NDC → |
| 0.1; 50 mg/mL; mg/mL | Topical | Dermal Source, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| EPINEPHRINE HYDROCHLORIDE 0.004 g/10 g; LIDOCAINE 0.3 g/10 g | Topical | SofTap Inc | UNAPPROVED DRUG OTHER | View NDC → |
| EPINEPHRINE HYDROCHLORIDE 0.1 mg/mL; LIDOCAINE HYDROCHLORIDE 50 mg/mL | Topical | Unit Dose, Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 0.1; 50 mg/mL; mg/mL | Topical | Unit Dose, Ltd. | OTC MONOGRAPH FINAL | View NDC → |
| 💊Topical spray | ||||
| 0.1; 50 mg/mL; mg/mL | Topical | Dermal Source, Inc. | OTC MONOGRAPH NOT FINAL | View NDC → |
| 0.1; 50 mg/mL; mg/mL | Topical | Dermal Source, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| LIDOCAINE HYDROCHLORIDE 5 g/100 mL; EPINEPHRINE HYDROCHLORIDE 0.01 g/100 mL | Topical | Scalp Tech Inc × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.01; 5 g/100 mL; g/100 mL | Topical | Scalp Tech Inc | OTC MONOGRAPH FINAL | View NDC → |
| 0.01; 5 g/100 mL; g/100 mL | Topical | Scalp Tech Inc | OTC MONOGRAPH DRUG | View NDC → |
| EPINEPHRINE HYDROCHLORIDE 0.1 mg/mL; LIDOCAINE HYDROCHLORIDE 50 mg/mL | Topical | Unit Dose, Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 0.1; 50 mg/mL; mg/mL | Topical | Unit Dose, Ltd. | OTC MONOGRAPH FINAL | View NDC → |
| 0.1; 50 mg/mL; mg/mL | Topical | Unit Dose, Ltd. | OTC MONOGRAPH DRUG | View NDC → |
Showing 156 of 156 products — FDA National Drug Code Directory. See every product, package size and price: browse all 156 Epinephrine / Lidocaine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Epinephrine / Lidocaine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Epinephrine / Lidocaine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Epinephrine / Lidocaine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 107602 10 dose forms · 22 strengths
-
Dose form (SCDF) Cartridge RxCUI 1657015No current FDA listingClinical drug / strength (SCD) 1.7 ML epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 12936481.7 ML epinephrine 0.02 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 16570261.8 ML epinephrine 0.02 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 1657016 -
Dose form (SCDF) Injectable Solution RxCUI 374456In current FDA listingsClinical drug / strength (SCD) epinephrine 0.002 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 1012155epinephrine 0.005 MG/ML / lidocaine hydrochloride 5 MG/MLRxCUI 1010745epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/MLRxCUI 1010751epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 1010759epinephrine 0.0125 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 1012169 -
Dose form (SCDF) Injection RxCUI 1867937In current FDA listingsClinical drug / strength (SCD) 5 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/MLRxCUI 186799810 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/MLRxCUI 186793810 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/MLRxCUI 186799210 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 186802820 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/MLRxCUI 101068830 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/MLRxCUI 186794330 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/MLRxCUI 1867996 -
Dose form (SCDF) Medicated Patch RxCUI 1793094No current FDA listingClinical drug / strength (SCD) epinephrine 0.001 MG/MG / lidocaine hydrochloride 0.1 MG/MGRxCUI 1116626 -
Dose form (SCDF) Prefilled Syringe RxCUI 1150119No current FDA listingClinical drug / strength (SCD) 3 ML epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/MLRxCUI 1150121 -
Dose form (SCDF) Rectal Foam RxCUI 2749267No current FDA listingClinical drug / strength (SCD) epinephrine hydrochloride 0.1 MG/ML / lidocaine hydrochloride 50 MG/MLRxCUI 2749269 -
Dose form (SCDF) Rectal Gel RxCUI 1733889No current FDA listingClinical drug / strength (SCD) epinephrine hydrochloride 0.0001 MG/MG / lidocaine hydrochloride 0.05 MG/MGRxCUI 1733890 -
Dose form (SCDF) Rectal Spray RxCUI 2601578No current FDA listingClinical drug / strength (SCD) epinephrine hydrochloride 0.1 MG/ML / lidocaine hydrochloride 50 MG/MLRxCUI 2601579 -
Dose form (SCDF) Topical Cream RxCUI 2719424In current FDA listingsClinical drug / strength (SCD) epinephrine 10 MG/ML / lidocaine 50 MG/MLRxCUI 2719425 -
Dose form (SCDF) Topical Spray RxCUI 1733891In current FDA listingsClinical drug / strength (SCD) epinephrine hydrochloride 0.1 MG/ML / lidocaine hydrochloride 50 MG/MLRxCUI 2462017
Look up RxCUI 107602 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Epinephrine / Lidocaine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 5 more on the FDA NDC directory.
RxNorm drug class
Epinephrine / Lidocaine belongs to the alpha-Adrenergic Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 50 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Fresenius Kabi USA, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.